Castle Creek Biosciences buys gene therapy company weeks after canceling IPO plans By: Philadelphia Business Journal via Business Journals January 10, 2022 at 14:55 PM EST The deal will enable the Exton company to expand both its new product pipeline and its technology platform. Read More >>
